72,234 articles
Moses V. Chao
Moses V. Chao is an American neuroscientist at NYU Grossman School of Medicine whose laboratory defined the NGF receptor genes and how neurotrophins act through a two-receptor system.
Moshe Arditi
Moshe Arditi is a physician-scientist in pediatric infectious diseases and immunology at Cedars-Sinai Medical Center in Los Angeles, known for research on Kawasaki disease and innate immune signaling.
Moshe Oren
Moshe Oren is an Israeli cancer molecular biologist at the Weizmann Institute of Science, known for his work on the p53 tumor suppressor protein and elected to the US National Academy of Sciences in 2019.
Moshe Phillip
Moshe Phillip (Hebrew: משה פיליפ) is an Israeli pediatric endocrinologist who has directed the National Center for Childhood Diabetes at Schneider Children's Medical Center, Petah Tikva, since 1997.
Moshe Szyf
Moshe Szyf is an epigeneticist and professor of pharmacology at McGill University, known for work on DNA methylation and for helping to found behavioral epigenetics.
Moshe Talpaz
Moshe Talpaz is a physician-scientist and professor of internal medicine at the University of Michigan whose work transformed treatment of chronic myeloid leukemia through interferon-alpha and imatinib.
Moshe Wolman
Moshe Wolman (1914–2009) was an Israeli physician and histochemistry researcher who co-described the fatal lipid storage disorder Wolman disease in 1956 and established Israel's first electron microscopy unit.
Moshé Yaniv
Moshé Yaniv, also known as Moshe Yaniv, is a molecular biologist at the Institut Pasteur in Paris known for work on DNA tumor virus chromatin and transcription control.
Mosquito
A mosquito is a small fly of the family Culicidae whose females take blood meals and transmit diseases that kill about 700,000 people a year.
Mosquito coil
Mosquito coil, a spiral mosquito-repellent incense invented in Japan in 1895 by Eiichiro and Yuki Ueyama; burns pyrethrin smoke for hours, emits PM2.5 equal to 75-137 cigarettes, and lacks proven malaria protection.
Mosquito control
Mosquito control reduces mosquito populations and biting to limit malaria, dengue, Zika, and West Nile transmission. Also called integrated vector management (IVM), it combines source reduction, larvicides, IRS, Wolbachia releases, and resistance monitoring.
Mosquito laser
Mosquito laser: directed-energy insect control, notably Intellectual Ventures' Photonic Fence (proposed 2006 by Lowell Wood, TED 2010 demo) and China's crowdfunded Photon Matrix, which detects flying mosquitoes with LiDAR and AI and kills them with steered laser pulses.
Mosquito Nets
A mosquito net is a lightweight meshwork fabric hung over a bed or crib to protect sleepers from mosquitoes. Insecticide-treated nets are a core WHO-recommended intervention for malaria control.
Mosquito-borne disease
Mosquito-borne disease: illnesses from parasites, viruses, or bacteria transmitted by Anopheles, Aedes, and Culex mosquitoes, including malaria, dengue, chikungunya, Zika, yellow fever, and West Nile; over 700,000 deaths yearly.
Mosquitocidal toxin
Mosquitocidal toxins (Mtx1, Mtx2, Mtx3) are soluble vegetative-growth toxins of Bacillus/Lysinibacillus sphaericus, toxic to Culex larvae and synergistic with Bin and Cry toxins, unlike the crystalline Bin toxin.
Mosquitofish
Mosquitofish (Gambusia affinis) are small live-bearing fish of the southeastern United States, introduced worldwide for mosquito control and now among the world's worst invasive fish.
Moss
Moss, or true mosses, is a small non-vascular land plant of the division Bryophyta, one of the three bryophyte phyla, with no flowers or seeds, absorbing water through its leaves and reproducing by spores.
Moss bioreactor
Moss bioreactor: contained photobioreactor culture of Physcomitrella patens protonema for recombinant pharmaceutical proteins, also called moss-made pharmaceuticals; distinguished by homologous-recombination glyco-engineering, 500 L GMP wave reactors, and the phase I Fabry disease drug aGal.
Moss graffiti and moss murals
Moss graffiti and moss murals are artworks made by applying living moss to walls in words or patterns, promoted as an aerosol- and solvent-free alternative to spray paint.
Moss in literature and media
Moss in literature and media covers the use of mosses as symbol and setting in poetry, fiction, film, and nature writing, from Shakespeare to Japanese gardens.
Moss lawn
Moss lawn: a ground cover of mosses used instead of turfgrass, also called a moss garden. Thrives in shade, damp acidic compacted soil; no mowing, spore reproduction, rhizoids, low traffic tolerance.
Moss walls and moss installations in interior design
A preserved moss wall is an interior feature of real moss or lichen treated with glycerin to stay soft without water, light, or maintenance, valued for texture and acoustics.
Mosses as bioindicators of air pollution
Mosses as bioindicators of air pollution describes how mosses absorb airborne metals and nitrogen into their tissue, so chemical analysis records the pollution reaching a site.
Mosses of Great Britain
Mosses of Great Britain: 795 moss species in Britain and Ireland per the 2020 checklist, about two-thirds of Europe's bryophyte flora, mapped in the 2014 Atlas from 2.83 million records, with 59 critically endangered species on the 2023 Red List.
Most probable number
The most probable number (MPN) method estimates the concentration of viable microorganisms, such as coliforms in water, milk, and food, from growth results across replicate dilution series.
Most recent common ancestor
Most recent common ancestor (MRCA) is the last individual from which a set of living organisms descends, such as in the converging maternal line of Mitochondrial Eve.
Mosunetuzumab
Mosunetuzumab (Lunsumio, Lunsumio Velo) is a humanized CD20 x CD3 bispecific T-cell engager antibody approved for relapsed/refractory follicular lymphoma after two or more systemic therapies, delivering 80% response rates via T-cell redirection.
Motacilla
Motacilla, the wagtails, a Linnaean 1758 genus of Motacillidae passerines with about 13 Old World species; eastern Palearctic origin about 4.5 million years ago, shaped by repeated dispersal rather than vicariance.
Motavizumab
Motavizumab (MEDI-524, Numax) is an unlicensed humanized IgG1 monoclonal antibody derived from palivizumab for RSV prophylaxis; 13 amino-acid changes gave higher F-protein affinity, but the FDA declined approval and AstraZeneca withdrew it in 2010.
Motesanib
Motesanib (AMG 706), an oral tyrosine kinase inhibitor targeting VEGFR 1-3, PDGFR, Kit, and Ret, developed by Amgen and Takeda for thyroid cancer and NSCLC; phase 3 trials failed and development was discontinued.